Exploring the Practicalities of Gynecologic Cancer Management as New Options Emerge

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing .. Read more medical education for physicians. Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This online, on-demand virtual symposium brings together renowned experts in gynecologic malignancies. This activity will serve as a comprehensive update for clinicians who treat a range of gynecologic cancers. This educational activity is directed toward medical oncologists, pathologists, surgical oncologists, and other clinicians involved in the management of patients with gynecologic cancers. Disclosures: Grant/Research Support: AstraZeneca, Clovis Oncology, Genmab/Seagen, ImmunoGen, Merck & Co.; Consultant: AstraZeneca, Clovis Oncology, Deciphera Pharmaceuticals, Genmab/Seagen, GlaxoSmithKline, Gradalis, ImmunoGen, Merck & Co., Toray.